- Type / Class
- Equity / Common Stock
- Shares outstanding
- 29,067,614
- Total 13F shares
- 27,342,861
- Share change
- -364,208
- Total reported value
- $4,929,918,497
- Put/Call ratio
- 33%
- Price per share
- $180.30
- Number of holders
- 298
- Value change
- -$51,223,771
- Number of buys
- 149
- Number of sells
- 139
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
4,314,014
|
$675,833,433 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
14%
|
4,033,872
|
$631,946,386 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
2,878,451
|
$450,938,134 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
9%
|
2,628,822
|
$411,831,255 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
4.4%
|
1,278,975
|
$218,154,766 | $0 | 31 Dec 2024 | |
| Capital World Investors |
13F
|
Company |
3%
|
879,203
|
$137,735,942 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
2.7%
|
788,460
|
$123,520,144 | — | 31 Dec 2024 | |
| Redmile Group, LLC |
13F
|
Company |
2.6%
|
753,175
|
$117,992,396 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
591,596
|
$92,700,536 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2%
|
588,599
|
$92,213,928 | — | 31 Dec 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.8%
|
512,726
|
$80,323,655 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
509,459
|
$79,812,000 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
358,379
|
$56,143,654 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
304,115
|
$47,642,656 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1%
|
303,521
|
$47,549,601 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.95%
|
277,175
|
$43,422,236 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.95%
|
275,195
|
$43,112,047 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.9%
|
262,263
|
$41,086,122 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.88%
|
256,275
|
$40,148,306 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.84%
|
243,170
|
$38,095,012 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.76%
|
221,102
|
$34,637,839 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.76%
|
219,528
|
$34,391,256 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.74%
|
215,628
|
$33,780,000 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
210,202
|
$32,930,245 | — | 31 Dec 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.69%
|
200,500
|
$31,410,330 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.63%
|
184,027
|
$28,829,669 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.58%
|
169,934
|
$26,621,860 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.58%
|
169,346
|
$26,529,799 | — | 31 Dec 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.55%
|
158,868
|
$24,888,261 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.52%
|
151,835
|
$23,786,471 | — | 31 Dec 2024 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.51%
|
149,309
|
$23,390,748 | — | 31 Dec 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.42%
|
123,453
|
$19,340,147 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
121,702
|
$19,065,835 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.39%
|
113,476
|
$17,778,838 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.39%
|
112,089
|
$17,559,863 | — | 31 Dec 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.36%
|
105,809
|
$16,576,000 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.35%
|
102,061
|
$15,988,876 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
100,131
|
$15,686,523 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.34%
|
99,633
|
$15,608,505 | — | 31 Dec 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
95,781
|
$15,005,051 | — | 31 Dec 2024 | |
| S Squared Technology, LLC |
13F
|
Company |
0.33%
|
95,215
|
$14,916,382 | — | 31 Dec 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.31%
|
89,047
|
$14,229,711 | — | 31 Dec 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.29%
|
85,300
|
$13,363,000 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.28%
|
81,328
|
$12,740,844 | — | 31 Dec 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.26%
|
76,772
|
$12,027,102 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.26%
|
75,799
|
$11,874,671 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
74,701
|
$11,702,659 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.24%
|
69,425
|
$10,876,120 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.24%
|
69,136
|
$10,830,821 | — | 31 Dec 2024 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.22%
|
63,010
|
$9,871,147 | — | 31 Dec 2024 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2025
As of 31 Mar 2025,
Krystal Biotech, Inc. - Common Stock (KRYS) was held by
298 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,342,861 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Capital World Investors, Redmile Group, LLC, Frazier Life Sciences Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This page lists
297
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
264
Q1 2025 holders
298
Holder diff
34
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.